Accelerate Diagnostics (AXDX) stock price, revenue, and financials

Accelerate Diagnostics market cap is $916.4 m, and annual revenue was $5.67 m in FY 2018

$916.4 M

AXDX Mkt cap, 21-Oct-2019

$1.8 M

Accelerate Diagnostics Revenue Q2, 2019
Accelerate Diagnostics Gross profit (Q2, 2019)899 K
Accelerate Diagnostics Gross profit margin (Q2, 2019), %49.8%
Accelerate Diagnostics Net income (Q2, 2019)-20.8 M
Accelerate Diagnostics EBIT (Q2, 2019)-18.1 M
Accelerate Diagnostics Cash, 30-Jun-201987.5 M
Accelerate Diagnostics EV954 M

Accelerate Diagnostics Income Statement

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

235.9k48.3k122.0k147.0k246.0k4.2m5.7m

Revenue growth, %

153%20%67%

Cost of goods sold

1.0m3.2m

Gross profit

3.2m2.5m

Gross profit Margin, %

76%44%

Sales and marketing expense

8.3k

R&D expense

431.9k10.7m20.1m26.0m28.2m22.3m27.6m

General and administrative expense

2.9m4.3m10.7m17.9m36.2m45.1m55.2m

Operating expense total

3.4m15.0m30.8m43.9m64.4m67.4m82.9m

Depreciation and amortization

362.5k888.0k1.8m2.4m

EBIT

(5.4m)(15.3m)(31.5m)(45.5m)(66.5m)(64.2m)(80.4m)

EBIT margin, %

(2269%)(31709%)(25834%)(30986%)(27033%)(1537%)(1417%)

Interest expense

10.1m

Interest income

16.3k33.5k64.0k74.0k494.0k908.0k2.8m

Pre tax profit

41.3k29.0k(31.5m)(45.5m)(66.1m)(63.5m)(88.1m)

Income tax expense

(1.8m)527.0k267.0k493.0k211.0k

Net Income

(5.3m)(15.3m)(30.9m)(45.5m)(66.4m)(64.0m)(88.3m)

Quarterly

USDQ2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

8.3k15.7k7.4k12.8k14.0k13.0k16.0k14.0k19.0k92.0k163.0k20.0k24.0k530.0k699.0k828.0k801.0k1.7m1.4m1.8m1.8m

Cost of goods sold

26.0k135.0k191.0k492.0k717.0k680.0k916.0k907.0k

Gross profit

504.0k564.0k637.0k309.0k975.0k675.0k834.0k899.0k

Gross profit Margin, %

95%81%77%39%58%50%48%50%

Sales and marketing expense

46.0

R&D expense

88.9k1.9m2.5m2.7m3.6m4.6m5.9m6.4m7.1m6.5m7.4m8.1m7.5m4.3m5.5m6.4m6.8m6.1m7.9m6.9m6.1m

General and administrative expense

198.3k629.0k1.2m1.1m2.0m3.4m2.6m2.9m4.8m4.3m7.4m9.2m9.3m10.5m11.5m11.6m14.4m15.3m12.2m12.7m12.8m

Operating expense total

287.2k2.5m3.7m3.7m5.6m8.0m8.6m9.2m11.9m10.8m14.8m17.3m16.8m14.8m17.0m18.0m21.1m21.4m20.0m19.7m19.0m

Depreciation and amortization

103.4k153.0k169.0k269.0k328.0k406.0k468.0k545.0k608.0k601.0k

EBIT

(343.6k)(2.6m)(3.8m)(3.8m)(5.7m)(8.2m)(8.8m)(9.6m)(12.3m)(11.2m)(15.2m)(17.9m)(17.4m)(14.3m)(16.4m)(17.3m)(20.8m)(20.4m)(19.4m)(18.8m)(18.1m)

EBIT margin, %

(4126%)(16270%)(51235%)(29668%)(41050%)(62808%)(55169%)(68271%)(64568%)(12182%)(9308%)(89445%)(72567%)(2700%)(2349%)(2091%)(2600%)(1207%)(1429%)(1076%)(1001%)

Interest expense

5.0k2.0k158.0k3.2m

Interest income

3.8k1.5k2.2k9.0k18.0k16.0k15.0k15.0k18.0k22.0k54.0k140.0k159.0k136.0k153.0k323.0k301.0k774.0k908.0k842.0k812.0k

Pre tax profit

20.4k1.5k1.0k55.018.0k13.0k13.0k(9.5m)(12.3m)(11.2m)(16.3m)(17.0m)(20.6m)(23.1m)(22.0m)(21.5m)(20.8m)

Income tax expense

647.0k175.0k45.0k184.0k101.0k147.0k221.0k17.0k

Net Income

(323.2k)(2.5m)(3.8m)(3.8m)(5.2m)(8.2m)(8.8m)(8.9m)(12.3m)(11.2m)(15.1m)(17.9m)(17.3m)(14.2m)(16.5m)(17.1m)(20.8m)(23.2m)(22.1m)(21.7m)(20.8m)

Accelerate Diagnostics Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

14.3m30.0m53.6m120.6m19.2m28.5m66.3m

Accounts Receivable

750.9k24.4k78.0k77.0k155.7m1.9m1.9m

Prepaid Expenses

17.9k130.2k342.0k1.6m850.0k980.0k

Inventories

10.3k8.1m7.7m

Current Assets

15.0m42.1m67.1m134.2m78.4m120.5m177.6m

PP&E

4.0k1.0m2.5m5.0m4.3m4.9m7.3m

Goodwill

1.5m

Total Assets

17.2m43.4m69.8m139.3m82.9m125.5m185.3m

Accounts Payable

63.0k540.4k2.1m2.6m992.0k2.1m1.3m

Short-term debt

209.8k162.4k

Current Liabilities

1.4m1.1m2.8m5.3m4.0m6.8m7.8m

Long-term debt

13.0k120.1m

Total Debt

209.8k13.0k120.1m

Total Liabilities

2.4m1.9m3.8m6.3m5.0m6.8m127.9m

Common Stock

219.9k516.0k44.6m51.2m55.7m54.2m

Preferred Stock

Additional Paid-in Capital

7.9m75.9m131.4m243.9m360.6m432.9m

Retained Earnings

(65.4m)(110.9m)(177.3m)(242.0m)(330.3m)

Total Equity

14.8m41.5m66.0m133.0m77.8m118.7m57.4m

Financial Leverage

1.2 x1 x1.1 x1 x1.1 x1.1 x3.2 x

Quarterly

USDQ2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

513.0k29.3m27.2m33.5m26.1m65.2m57.9m47.4m35.2m25.2m72.0m37.5m28.7m9.9m62.6m34.4m126.8m66.8m61.6m75.3m87.5m

Accounts Receivable

595.9k793.5k818.4k106.2k40.0k40.0k89.0k92.0k143.0k742.0k77.0k169.0k159.0k551.0k682.0k1.1m1.1m1.8m1.4m2.0m1.9m

Prepaid Expenses

41.1k92.1k122.0k115.0k969.0k616.0k677.0k473.0k1.0m1.1m2.3m1.6m1.3m1.0m1.2m1.0m1.5m1.4m940.0k1.9m1.3m

Inventories

30.3k4.4m5.7m7.3m10.1m11.3m9.4m8.6m8.3m

Current Assets

1.2m30.1m28.1m44.6m39.6m79.7m72.7m59.7m49.4m40.9m120.3m105.4m91.7m70.3m143.3m131.3m207.1m212.6m192.9m164.0m150.2m

PP&E

2.5k776.9k930.0k1.0m1.6m1.9m2.3m3.5m3.8m3.7m5.2m5.0m4.8m3.9m4.8m4.7m5.9m5.4m7.4m7.2m7.6m

Goodwill

1.4m

Total Assets

6.0m31.2m29.3m45.9m41.4m81.8m75.2m63.3m53.3m44.8m125.6m110.5m96.6m74.4m148.3m136.1m213.1m218.3m200.7m172.2m158.6m

Accounts Payable

101.3k29.0k321.7k6.8k718.0k1.3m1.1m2.4m1.7m1.6m2.7m1.8m2.4m1.3m1.5m1.4m2.8m2.4m1.6m2.5m1.8m

Short-term debt

104.6k124.0k143.2k181.0k

Current Liabilities

231.0k1.1m1.8m411.9k1.7m2.3m2.1m3.5m3.0m3.6m5.0m4.5m4.4m5.2m6.2m6.2m7.5m7.8m5.5m6.5m7.5m

Long-term debt

124.0k87.0k50.0k99.2m115.5m117.8m122.7m125.1m

Total Debt

104.6k124.0k143.2k305.0k87.0k50.0k99.2m115.5m117.8m122.7m125.1m

Total Liabilities

1.7m1.1m1.8m938.6k2.6m3.1m2.9m4.5m4.0m4.6m6.0m5.5m5.4m5.3m6.2m6.2m106.6m123.4m123.3m129.2m132.6m

Common Stock

10.8m38.8m38.8m41.5m41.9m45.0k44.6m44.7m44.7m44.7m51.0k51.0k51.0k52.0k55.0k55.0k54.0k54.0k54.0k54.0k55.0k

Preferred Stock

Additional Paid-in Capital

1.5m51.8m53.0m74.3m78.4m126.5m128.9m133.1m135.9m137.9m245.6m248.8m252.3m261.4m350.6m355.5m414.3m426.1m430.7m440.2m443.9m

Retained Earnings

(74.3m)(86.6m)(97.8m)(126.0m)(143.9m)(161.2m)(192.1m)(208.6m)(225.7m)(262.8m)(286.1m)(308.2m)(352.1m)(372.9m)

Total Equity

4.4m30.1m27.5m45.0m38.8m78.7m72.3m58.8m49.4m40.2m119.7m105.0m91.2m69.1m142.0m129.9m106.5m94.9m77.4m43.0m26.0m

Financial Leverage

1.4 x1 x1.1 x1 x1.1 x1 x1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1 x1 x2 x2.3 x2.6 x4 x6.1 x

Accelerate Diagnostics Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(5.3m)(15.3m)(30.9m)(45.5m)(66.4m)(64.0m)(88.3m)

Depreciation and Amortization

2.1k362.5k888.0k1.8m2.4m2.2m2.6m

Accounts Receivable

(590.6k)(739.5k)54.0k1.0k43.0k(1.9m)86.0k

Inventories

(20.0k)(7.8m)(4.2m)

Accounts Payable

28.1k204.2k1.3m329.0k(1.2m)1.1m(748.0k)

Cash From Operating Activities

(815.7k)(9.7m)(18.8m)(35.1m)(53.4m)(55.7m)(67.8m)

Purchases of PP&E

(95.5k)(1.2m)(3.7m)(2.4m)(3.0m)(998.0k)

Cash From Investing Activities

(245.5k)(13.2m)(3.4m)(2.7m)(49.6m)(25.7m)(20.1m)

Long-term Borrowings

107.0k(147.0k)(13.0k)

Cash From Financing Activities

14.5m40.9m45.7m104.8m1.8m90.4m125.8m

Net Change in Cash

13.5m18.0m23.5m67.0m(101.3m)9.3m37.7m

Interest Paid

2.0m

Income Taxes Paid

651.0k

Quarterly

USDQ2, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

(753.5k)(2.5m)(6.3m)(10.1m)(5.2m)(13.4m)(22.2m)(8.9m)(21.1m)(32.3m)(15.1m)(32.9m)(50.2m)(14.2m)(30.7m)(47.7m)(20.8m)(44.0m)(66.1m)(21.7m)(42.5m)

Depreciation and Amortization

1.0k36.4k107.0k248.9k153.0k323.0k592.0k328.0k734.0k1.2m545.0k1.1m1.8m508.0k2.1m1.6m544.0k1.1m1.7m626.0k1.2m

Accounts Receivable

(213.0)29.6k54.5k(657.7k)16.0k16.0k65.0k14.0k65.0k664.0k(92.0k)(82.0k)(522.0k)(648.0k)(1.1m)881.0k123.0k506.0k(90.0k)(51.0k)

Inventories

(4.2m)(5.5m)(7.1m)(1.9m)(4.3m)(5.2m)(1.6m)(2.2m)

Accounts Payable

66.4k(270.7k)22.0k(292.9k)125.0k496.0k528.0k166.0k(129.0k)(329.0k)494.0k(394.0k)103.0k276.0k528.0k359.0k701.0k206.0k(524.0k)1.2m476.0k

Cash From Operating Activities

(156.8k)(2.3m)(4.2m)(7.0m)(3.7m)(7.8m)(14.0m)(7.0m)(16.4m)(25.2m)(13.2m)(28.1m)(40.6m)(15.5m)(28.1m)(42.5m)(16.1m)(35.4m)(53.4m)(19.5m)(33.6m)

Purchases of PP&E

31.0k(675.1k)(896.7k)(1.1m)(424.0k)(729.0k)(1.4m)(1.7m)(2.1m)(2.3m)(229.0k)(1.6m)(2.1m)(1.3m)(702.0k)(842.0k)(37.0k)(76.0k)

Cash From Investing Activities

(106.0k)(675.1k)(896.7k)(12.0m)(938.0k)(2.7m)(3.7m)761.0k(2.2m)(3.6m)(34.5m)(55.2m)(52.2m)4.1m(16.0m)(30.9m)12.5m(50.7m)(39.0m)24.8m50.2m

Long-term Borrowings

(13.0k)(13.0k)(13.0k)

Cash From Financing Activities

20.1m20.2m40.4m724.0k45.7m45.5m30.0k254.0k432.0k(799.0k)259.0k983.0k2.0m87.3m88.3m101.8m124.5m125.6m3.8m4.6m

Net Change in Cash

(262.8k)17.2m15.1m21.4m(3.9m)35.2m27.8m(6.2m)(18.3m)(28.4m)(48.6m)(83.1m)(91.9m)(9.3m)43.4m15.2m98.3m38.3m33.1m9.0m21.2m

Interest Paid

2.0m2.1m2.1m

Income Taxes Paid

435.0k2.0k9.0k

Accelerate Diagnostics Ratios

USDY, 2019

EV/EBIT

-52.7 x

EV/CFO

-28.4 x

Financial Leverage

6.1 x

Accelerate Diagnostics Employee Rating

4.443 votes
Culture & Values
4.6
Work/Life Balance
3.4
Senior Management
4.0
Salary & Benefits
4.0
Career Opportunities
4.1
Source